Finance

Medical device company reports product development milestones

Published in Drug Week, July 30th, 2004

Andromed, Inc., (AD), an innovative medical technologies company, reported on its operations and financial results for the quarter ended May 31, 2004.

Important product development milestones have been achieved during the quarter and the benefits of the new business plan begin to materialize.

1) Androsonix, the non-invasive single-use acoustic biosensor, continues to bolster its potential as business opportunities arise at various levels of the patient monitoring industry, for which the global markets is estimated at more than U.S.$6 billion.

2) Positive results were announced in April 2004 for these two applications. Based on the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-07-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry